TABLE 4:

Spatial localization of elevated Lac and Lip levels compared with morphologic abnormalities after surgery

PatientPathologyElevated LacElevated Lip
Resection CavityCET2-CEResection CavityCET2-CE
7*OD2NoNoNoNoNoNo
8A2NoNoNoNoNoNo
9A2NoNoNoNoNoNo
10OD2NoNoNoNoNoNo
11OD2NoNoNoNoNoYes
12OD2NoNoNoYesNoNo
13OA2NoNoYesNoNoNo
14OA2NoNoNoNoNoNo
15A2YesNoNoYesYesNo
16A2YesYesYesYesNoNo
17A2NoNoYesNoNoYes
21*AA3NoNoNoNoNoNo
22*OD3NoNoNoNoNoNo
26*GBMYesNoNoYesNoNo
27*GBMYesNoNoNoNoNo
28*GBMYesYesYesYesYesNo
29*GBMNoNoNoYesNoNo
30*GBMNoNoNoNoNoNo
31*GBMYesNoNoNoNoNo
32*GBMYesNoNoNoNoNo
33*GBMYesNoNoNoNoNo
34GBMNoYesNoNoYesNo
35GBMYesYesYesYesYesNo
36GBMNoNoNoNoNoNo
37GBMYesNoNoYesYesNo
38GBMYesNoNoNoYesNo
39GBMYesYesNoNoNoNo
  • Note.—Data after surgical resection or biopsy but before radiation treatment or chemotherapy. CE indicates contrast enhancement; T2-CE, regions within T2 hyperintensity but outside contrast enhancement; A2, grade-II astrocytomas; OA2, grade-II oligoastrocytomas; OD2, grade-II oligodendrogliomas; AA3, grade-III anaplastic astrocytomas; OA3, grade-III oligoastrocytomas; OD3, grade-III oligodendrogliomas.

  • * Patients with both presurgical and postsurgical data.